AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2013

Nov 18, 2013

32227_dirs_2013-11-18_f4185ba1-33a3-490a-b0f8-cf370c7345d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2013-11-18

Reporting Person: ROSS STEVEN A (CIO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$3.93	2018-04-22	Common Stock (150000)		Direct

Footnotes

F1: These stock options were granted to Mr. Steven A. Ross upon upon beginning employment with NeoGenomics and vest ratably over each of his first four anniversaries with the Company.